ASRS 2020: Dexamethasone intracameral drug-delivery suspension in vitreoretinal surgery inflammation

Name: ASRS 2020: Dexamethasone intracameral drug-delivery suspension in vitreoretinal surgery inflammation
Uploaded: 2020-08-03T15:40:34.185Z
Description: Daniel F. Kiernan, MD, FACS, speaks on the key findings and take-aways of his presentation "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery."

August 3, 2020

Alex Delaney-Gesing

Video

Conference|ASRS

Daniel F. Kiernan, MD, FACS, speaks on the key findings and take-aways of his presentation "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery."

Daniel F. Kiernan, MD, FACS, speaks with Ophthalmology Times®' David Hutton on the key findings and take-aways from his presentation, "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery," during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

See more ASRS meeting coverage here